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Background: Fast Fixation is necessary to study real-time protein-protein interactions under physiological conditions.
Fast formaldehyde cross-linking can fix transient and weak protein interactions, thereby reducing the number of false
negatives but producing great complexity. To reduce this complexity, immunoaffinity purification can Fish out
complexes that include particular target proteins, but affinity-based co-purification has a limited capacity to eliminate
nonspecific binding to beads and/or antibodies. To Filter out these complexes, SDS-PAGE is used to disrupt
non-covalent bonds, thereby eliminating uncross-linked complexes and simultaneously providing molecular weight
information for identification.
Results: We described a 4 F strategy to help improve real-time ligands discovery based on formaldehyde crosslinking,
immunoprecipitation and SDS-PAGE separation: Fast Fix, Fish, and Filter, using albumin interactome as an example. The
use of gel excision without staining makes this strategy comprehensive and sensitive. The target protein must be
identified in the same slice as its ligands. The ligands must be identified in slices for the experimental group but not in
the corresponding control slices. Only proteins that appear in the range of molecular weights equal to or greater than
the sum of the proteins’ theoretical molecular weights, together with the target, are considered ligands. In this study,
5 s of cross-linking with 10% formaldehyde was achieved in human blood. The use of this strategy identified 35
ligands for albumin. Comparison with four major previous studies of the albuminome revealed that 68.57% of the 35
ligands identified in our study were identified in these other studies.
Conclusions: Fast cross-linking was achieved. The 4 F strategy can be used to identify real-time in situ interactions
without prior intervention and to comprehensively identify ligands of particular target proteins with fewer false positives.
Keywords: Albumin, Formaldehyde cross-linking, Immunoprecipitation, Mass spectrometry, Protein-protein interactionsBackground
Identifying real-time protein-protein interactions is a first
step in revealing the mechanisms underlying biological
processes. Few proteins function alone, with most func-
tioning in the form of protein complexes. Proteins tend to
form various complexes that are constantly associating
and disassociating. Transient protein-protein interactions,* Correspondence: gaoyouhe@pumc.edu.cn
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reproduction in any medium, provided the orsuch as reversible substrate-enzyme binding and receptor-
ligand interactions, some of which are weak interactions,
are fundamental to many biological processes.
Chemical cross-linking is a useful high-throughput
method for studying in situ protein-protein interactions
and is able to capture transient and weak interactions. In
general, two strategies have been developed in previous
cross-linking studies, cross-linking with [1] or without
cross-link reversal [2]. In studies without cross-link re-
versal, the gel is usually stained, and bands of interest
are excised and analyzed using LC-MS/MS [2]. Formal-
dehyde is a powerful zero-length cross-linking reagent. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the stability of complexes [3]. The reactions take place
rapidly and can be quenched immediately. Formaldehyde
has been used for fixation in experiments based on im-
munohistochemistry, chromatin immunoprecipitation of
protein-DNA complexes, mass spectrometry-compatible
silver staining, and the examination of protein-protein in-
teractions [3,4]. Paraformaldehyde cross-linking coupled
with immunoaffinity chromatography and mass spectrom-
etry has been employed to identify interacting partners of
M-Ras, but the shortest incubation time used was 5 min
[1]. The amount of cross-linking products generated is de-
termined by the number of protein-protein interactions
that exist and the extent of cross-linking. As shown in
previous studies, the formaldehyde concentration and in-
cubation time are complementary parameters that can be
tuned to achieve efficient cross-linking [5]. Fast Fixation
with a relatively high formaldehyde concentration pro-
vides, in effect, a faster shutter speed for capturing images
of protein-protein interactions.
Commonly used purification methods, such as co-
immunoprecipitation, can Fish out target protein com-
plexes. When this strategy is used, stringent washing
during immunoprecipitation is unnecessary to remove
contaminants, which can be eliminated by comparison
with the control. SDS-PAGE is employed to disrupt non-
covalent bonds, thereby eliminating uncross-linked com-
plexes and, at the same time, providing molecular weight
information as an identification Filter.
To obtain true ligands, the two following conditions are
required to hold for the proteins in the SDS-PAGE gel
after fast cross-linking and immunoprecipitation (Figure 1):
1. the target protein has to be identified in the same slices
as the ligands, and 2. the molecular weight of the com-
plexes has to be the sum of the theoretical MWs of the
target and the ligand. a) Ligands are not identified in the
control, as observed for L1 and L3. b) Target complexes
bind to the beads nonspecifically after cross-linking. To be
conservative, the ligand should be identified at a MW
higher than that of the control (> = 300 kDa) and outside
of the neighboring range (250–300 kDa), as for L2. (L2-T-
L3 is an example of a complex with interactions other than
binary interactions.) Proteins identified in the same range
as in the control group or in a neighboring range are elim-
inated as contaminants and are not shown in the figure.
Albumin was used as an example to illustrate the 4 F
strategy.
Results and discussion
Determination of fast fixation conditions
To achieve fast fixation, a 5 s fixation period was tested.
Freshly drawn blood was directly added to various con-
centrations of formaldehyde. Sufficient amounts of 4 M
Tris were used to stop the cross-linking reactions. Thereaction times were strictly controlled. Samples containing
equal volumes of the original blood sample were loaded.
When using a 5 s duration for the transient cross-linking
reaction, the use of formaldehyde at a concentration of 5%
or higher for cross-linking resulted in a distinctly different
appearance compared with that of the control (Figure 2a).
The patterns obtained using 10% and higher concentra-
tions of formaldehyde for cross-linking were similar, indi-
cating that 10% formaldehyde was sufficient for fixing
protein-protein interactions in the blood.
To determine whether 5 s was sufficient for cross-linking,
longer incubation times with 10% formaldehyde were
tested. The patterns obtained with longer incubation times
exhibited no obvious differences. There were differences
between the patterns for 0 s cross-linking and 0% formalde-
hyde cross-linking, and the bands at approximately 15 kDa,
25 kDa and 35 kDa might have been caused by hemolysis.
The electrophoresis patterns observed for the two sets of
cross-linked samples from the two volunteers were nearly
the same, indicating good biological and technical reprodu-
cibility (Additional file 1: Figure S1).
In the Western blots produced using an albumin anti-
body (Figure 2b), two bands and smears at molecular
weights higher than that of albumin were observed in all
of the cross-linked samples but not in the controls. Higher
concentrations and longer cross-linking times did not re-
sult in a significant increase in the number of cross-linking
products obtained. Therefore, a 5 s cross-linking time in
10% formaldehyde was chosen for the following experi-
ments. However, most of the albumin molecules existed in
an uncross-linked state.
Identification of albumin ligands
To identify the interacting partners of the target protein,
an excess of antibody was used for immunoprecipitation
to purify sufficient amounts of cross-linked products for
MS analysis. After immunoprecipitation, a 4-12% denatur-
ing gradient gel was used to achieve good separation of
protein complexes with high molecular weights. Without
staining, the portion of the gel corresponding to molecular
weights greater than 70 kDa was excised and sectioned
into six slices using the molecular weight markers as a
guide. Samples from the experimental group and control
group were analyzed using LC-MS/MS. Different LC
columns were used for the samples and controls to re-
duce cross-contamination.
After the Mascot search, the significance threshold and
ion score cut-off were set to 0.05 using MudPIT protein
scoring. The original peptide sequences for identified pro-
teins in each molecular weight range can be referenced in
additional file (Additional file 2: Table S1). Only proteins
that had at least two significant sequences were reported
using the report builder. Proteins in the contaminants
database or that contained “keratin” or “keratinocyte” in
Figure 1 Principle of the 4 F strategy. T: target protein, L: ligand. Without staining, the portion of the gel corresponding to molecular weights
above that of a single albumin molecule (70 kDa) was excised in six slices using the protein markers as a guide. The slices corresponded to MWs
of 70–100 kDa, 100–130 kDa, 130–180 kDa, 180–250 kDa, 250–300 kDa, and greater than 300 kDa. 1. The target protein has to be identified in the
same slice as the ligands. 2. The molecular weight of each complex is the sum of the theoretical MWs of the target and the ligand. a) Ligands are
not identified in the control, as observed for L1 and L3. b) Target complexes bind to the beads nonspecifically after cross-linking. To be conservative,
the ligand should be identified at a MW higher than that of the control (> = 300 kDa) and outside of the neighboring range (250–300 kDa), as for L2.
(L2-T-L3 is an example of a complex with interactions other than binary interactions). 3. Proteins identified in the same range as in the control group
or in a neighboring range are eliminated as contaminants and are not shown in the figure.
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the experimental groups, and 33 were identified in the
control samples (Additional file 3: Table S2).
To identify true ligands, the following two conditions
are required (as illustrated in Figure 1): 1. the target pro-
tein must be identified in the same slice as the ligands,
and 2. the molecular weight of a complex must be the
sum of the theoretical MWs of the target and the ligand.
a) Ligands are not identified in the control, as observed
for L1 and L3. b) Target complexes bind to the beads
nonspecifically after cross-linking. To be conservative,
the ligand should be identified at a MW higher than that
of the control (> = 300 kDa) and outside the neighboring
range (250–300 kDa), as for L2. (L2-T-L3 is an example
of complexes with interactions other than binary inter-
actions). Proteins identified in the same range as in the
control group or in a neighboring range are eliminated
as contaminants and are not shown in the figure. A total
of 35 proteins were considered to be albumin ligands
(Table 1), 27 of which were not identified in the control.
Peptide match data for above identified albumin ligands
were listed in Table S2 (Additional file 4: Table S3).
The comparison of the 35 albumin ligands with the 1926
plasma proteins listed in order of descending abundance
based on peptide-spectrum matches (Farrah T et al.) [6] in-
dicated that the cross-linking products were not produced
by random cross-linking with highly abundant proteins in
the blood. Only 5 of the top 20 and 15 of the top 100
plasma proteins were identified as albumin ligands in ourresults. The four most abundant proteins, which include al-
bumin, transferrin, alpha-1-antitrypsin, and retinol-binding
protein 4, were not identified as ligands. In addition, the
abundances of ten ligands identified in our study are so low
that these proteins are not even present in the human
plasma proteome reference set (Farrah T et al.) [6].
Albumin has many ligands and is a member of many
complexes. Thus, albumin was present in every slice in
the experimental group in this study. Other target pro-
teins with fewer ligands may be present in only narrow
molecular weight ranges.
When this strategy is used, stringent washing during
immunoprecipitation is unnecessary to exclude contami-
nants because they can be eliminated by comparison
with the control. Because albumin was immunoprecipi-
tated using gentle washing and because albumin is the
most abundant protein in the blood, it was also present
in the control slices. Other target proteins may not ap-
pear in the control slices as often.
Irrelevant cross-linked complexes exhibiting nonspecific
binding to beads and proteins with post-translational mod-
ifications might appear in slices corresponding to higher
molecular weights than those of potential complexes. A
control consisting of a cross-linked sample without an
antibody was used to eliminate both possibilities, which
cannot be achieved using an uncross-linked control. To
be conservative, the proteins in the experimental sam-
ples that appeared in the corresponding slice as in the con-
trol samples or in a neighboring slice were not considered
Figure 2 Formaldehyde cross-linking of human blood samples. Human blood was incubated with various concentrations of formaldehyde
for 5 s or with 10% formaldehyde for various times: (a) samples were analyzed using SDS-PAGE and (b) samples were analyzed using Western
blotting with an anti-albumin antibody.
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CO3_HUMAN), 31 spectra were identified in the molecu-
lar range of 130–180 kDa in the control, and the 43 and 49
spectra identified in the corresponding range of 130–
180 kDa and the neighboring range of 180–250 kDa were
not sufficient to warrant accepting complement C3 (P01
024, CO3_HUMAN) as a true ligand. In total, 55 spectra
identified in the 250–300 kDa slice qualified as true ligands
in this study, as for L2 in Figure 1.
Two obvious bands observed in the Western blots fell
in the observed molecular weight ranges of 70–100 kDa
and 130–180 kDa, and these bands could not be explained
by the identified ligands. These bands might have been
due to the presence of dimeric or modified albumin.AMBP, alpha-1-microglobulin/bikunin precursor, has
been reported to interact with albumin [7]. Albumin-
AMBP complexes were isolated using anti-AMBP affin-
ity chromatography and were separated under native
conditions. The complexes were a mixture of 1:1 and 1:2
complexes, with masses determined by SDS/PAGE of
approximately 100 kDa and 135 kDa, respectively [7].
The plasma concentration of albumin-AMBP was esti-
mated to be 5.2 mg/L [7]. If the molecular weight cri-
teria had not been applied, the AMBP protein would
have been regarded as a contaminant because it also ap-
peared in the control group.
AMBP has also been reported to form a complex with
A2M [8]. The total theoretical molecular weight of the





Observed MW range (kDa)
≥300 250-300 180-250 130-180 100-130 70-100
P02768 ALBU_HUMANa 71.317 59 (45) 184 (68) 269 (109) 418 (74) 328 (70) 516 (103)
P02760 AMBP_HUMANa 14 39.886 8 2 0 (3)
P01024 CO3_HUMANa 12, 13, 14 188.569 55 49 43 (31) 3
P15924 DESP_HUMANa 13 334.021 3 0 (2)
P02671 FIBA_HUMANa 11, 12, 13, 14 95.656 8 23 10 6 (5) 8 5 (15)
P69905 HBA_HUMANa 13 15.305 3 9 10 9 19 (4) 16 (8)
P01871 IGHM_HUMANa 12, 14 49.96 2 8 9 3 3 4 (29)
P12273 PIP_HUMANa 16.847 3 7 0 (2)
P00747 PLMN_HUMANa 12, 13, 14 93.247 2 3 30 (3)
P01023 A2MG_HUMAN 12, 14 164.613 13 53 47
P02647 APOA1_HUMAN 11, 12, 13, 14 30.759 3 2
P05090 APOD_HUMAN 12, 14 21.547 7
P02730 B3AT_HUMAN 102.013 3 4 4 2 19 5
P04040 CATA_HUMAN 59.947 2
P00450 CERU_HUMAN 12, 13, 14 122.983 2
P00751 CFAB_HUMAN 11, 12, 13, 14 86.847 5
P16452 EPB42_HUMAN 77.816 4
Q01469 FABP5_HUMAN 15.497 7
P02675 FIBB_HUMAN 12, 14 56.577 7 30 23 21 15 2
P02679 FIBG_HUMAN 12 52.106 23 10 7 8
P05155 IC1_HUMAN 11, 13, 14 55.347 2
P01857 IGHG1_HUMAN 11, 12, 14 36.596 8 11 27 31 20
P01859 IGHG2_HUMAN 11, 12, 14 36.505 3 6 9
P01860 IGHG3_HUMAN 12, 14 42.287 8 19 22 14
P01861 IGHG4_HUMAN 14 36.431 19
P01834 IGKC_HUMAN 11, 12, 14 11.773 2 5
B9A064 IGLL5_HUMAN 23.391 3
P06312 KV401_HUMAN 13.486 17
P0CG04 LAC1_HUMAN 12, 14 11.512 4 7
P47929 LEG7_HUMAN 15.123 2
P32119 PRDX2_HUMAN 22.049 4 4
P31151 S10A7_HUMAN 11.578 8
P06702 S10A9_HUMAN 14 13.291 10
P29508 SPB3_HUMAN 44.594 9
P04004 VTNC_HUMAN 12, 13, 14 55.069 3
P25311 ZA2G_HUMAN 13 34.465 4
Total spectrum counts in each MW range 40 288 184 147 173 71
aAlbumin and ligands also identified in the control.
The spectrum counts for the control are listed in brackets.
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ment, both AMBP and A2M were identified in the range
of 250–300 kDa, indicating that the complex was cross-
linked and captured by the anti-albumin antibody.Comparison with previous studies addressing
albumin-binding proteins
Albumin binds proteins and peptides [9,10]. Four major
studies have been conducted on the human albuminome,
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anti-albumin antibody, an anti-albumin column or an al-
bumin column directly. Totals of 125 (Zhou, M. et al.)
[11], 50 (Gundry, R. et al.) [12], 62 (Scumaci, D. et al.) [13]
and 151 (Holewinski, R. et al.) [14] ligands were identified
in these studies. The comparison of our results with those
of these four albuminome studies revealed that 68.57% of
the 35 ligands identified in our study were also identified
in these previous studies (Table 1). Eleven ligands were
identified only by our strategy.
Low-molecular-weight proteins/peptides that associate
with albumin and five other high-abundance proteins in
the serum have been studied using affinity columns [11].
However, the use of different elution conditions resulted
in poor overlap. Twenty-eight ligands were identified using
antibody immunoprecipitation, and 107 ligands were iden-
tified using an affinity column in the same study. Only 10
of these ligands were identified by both methods.
Conclusions
This study represents the first use of transient cross-
linking to identify protein-protein interactions. The use
of fast fixation and molecular weight filtering in this new
method reduces the number of random results and makes
the results comprehensive and precise. In addition, gel ex-
cision without staining makes this 4 F strategy sensitive.
Stringent washing during immunoprecipitation is unneces-
sary for excluding contaminants because they can be elimi-
nated by comparison with the control.
When this strategy is used, only proteins that simul-
taneously satisfy the following three criteria can be con-
sidered false positives: 1. the putative ligand binds to the
antibody by forming a complex with other proteins; 2.
the protein is present in ranges with molecular weights
equal to or greater than the sum of the theoretical mo-
lecular weights of the potential ligands plus the target pro-
tein in SDS-PAGE; and 3. the protein is present in the
same range as the target protein.
False negatives can occur only when formaldehyde can-
not access the protein interaction interface within the al-
lotted cross-linking time.
The use of this strategy identified 35 ligands for albu-
min. Comparison with the results of three previous major
studies of the albuminome revealed that 68.57% of the 35
ligands identified in our study were identified in previous
albuminome studies.
There was a concern that the action of adding blood
samples to formaldehyde might result in unnatural pro-
tein contacts and produce random cross-linking. In this
case, higher-abundance proteins should have been more
likely to bind to albumin. However, the four most abun-
dant proteins [6], which include albumin, transferrin,
alpha-1-antitrypsin, and retinol-binding protein 4, were
not identified as ligands. This potential problem may notaffect the results when 4 F strategy is used to analyze
cells or tissues.
This 4 F strategy can be used to identify real-time in
situ interactions without prior intervention and to com-
prehensively identify ligands of particular target proteins
with fewer false positives. Therefore, this method can




The two healthy volunteers had provided written informed
consent to participate in the study and publish these case
details. The Institutional Review Board (IRB) of Institute
of Basic Medical Sciences, Chinese Academy of Medical
Sciences had approved this consent procedure. The project
number is 019–2013.
The IRB had approved the blood draw procedure and
had reviewed the proposed use of human subjects in the
above-mentioned project. The right and the welfare of
the subjects are adequately protected; the potential risks
are outweighed by potential benefits.
Antibodies and reagents
Formaldehyde was purchased from Sinopharm Chemical
Reagent Co., Beijing. Ultrapure Tris was purchased
from the USB Corporation (Affymetrix, Santa Clara,
California, USA). All of the antibodies used were purchased
from commercial sources. These antibodies included a
mouse monoclonal anti-human serum albumin antibody
for immunocytochemistry applications (ab10241, Abcam,
Boston, MA, USA) and a peroxidase-conjugated AffiniPure
goat anti-mouse IgG (H+ L) (ZB-2305, ZSGB-bio, Beijing,
China). Protein A +G agarose for co-immunoprecipitation
was purchased from the Beyotime Institute of Biotechnol-
ogy (P2012, Shanghai, China). PBS for washing was ob-
tained from the Cell Culture Center at Peking Union
Medical College (Beijing, China).
For protein electrophoresis, 1.5 mm × 10 well 4-12%
Bis-Tris gels (NuPAGE, Life Technologies, Carlsbad,
California, USA) were used. The 5× SDS loading buffer was
obtained from Genestar (Shanghai, China), and the 1851
protein marker was obtained from Fermentas (Waltham,
Massachusetts, USA). For trypsin digestion, trypsin gold of
mass spectrometry grade was purchased from Promega
(Madison, WI, USA). IAA (iodoacetamide) was purchased
from GE (Fairfield, Connecticut, USA), and DTT (dithio-
threitol) was purchased from Merck (Whitehouse Station,
New Jersey, USA). All other regents were of high purity.
Fast formaldehyde cross-linking
Solutions of 40% formaldehyde were diluted to 1%, 5%,
10%, and 20% using double-distilled water. The final
mass concentration of NaCl was 0.9% in the diluted
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4 mL of these formaldehyde solutions were prepared.
For the quenching of the different concentrations of for-
maldehyde, 4 M Tris, pre-prepared in 50 mL tubes, was
used. A volume of 2 mL was used for formaldehyde con-
centrations of 10% and below, 4 mL was used for 20%
formaldehyde, and 8 mL was used for 40% formaldehyde.
Freshly drawn blood samples (5 mL) were collected from
two healthy male volunteers into tubes without anticoagu-
lants and divided carefully into several 1.5 mL Eppendorf
tubes. Aliquots of 0.5 mL of blood were added to the
50 mL tubes containing formaldehyde. After cross-linking,
4 M Tris was added, and the contents of the tubes were
mixed gently. The cross-linking times were strictly con-
trolled. Mixing formaldehyde and Tris before adding to
blood is the control of 0 s cross-linking. After cross-
linking and quenching, the samples were centrifuged at
300 g for 10 min at 4°C, and the supernatants were then
dispensed into small aliquots and stored at -80°C. All of
the samples used were thawed only once. Hemolysis oc-
curred after quenching with Tris but was ignored because
it had no impact in this study.
Immunoprecipitation and SDS-PAGE separation
To capture all of the cross-linked and uncross-linked albu-
min, an excess of antibody was used for immunoprecipita-
tion. Two 70 μL cross-linking samples from one volunteer
were diluted with 500 μL of PBS and precleared twice with
150 μL of beads each time and were then incubated with
125 μL (250 μg) of an anti-human serum albumin anti-
body or PBS for 16 hours. Then, 200 μL of Protein A +G
agarose beads was added, followed by incubation for
3 hours. The agarose beads were washed five times using
PBS (1 mL per wash). After the last wash, the supernatant
was discarded, and the agarose beads were resuspended in
320 μL of 2.5 × SDS loading buffer (160 μL for the control
group) at 4°C before use. The samples were heated for
10 min at 65°C before electrophoresis [1]. Aliquots of
20 μL of the supernatants were loaded into the lanes of
4-12% SDS-PAGE gels.
LC-MS/MS
Without staining, the portion of each gel corresponding to
molecular weights above that of a single albumin molecule
(70 kDa) was excised in six slices using the protein markers
as a MW guide. The slices corresponded to MWs of 70–
100 kDa, 100–130 kDa, 130–180 kDa, 180–250 kDa, 250–
300 kDa, and greater than 300 kDa. All of the slices were
subjected to overnight in-gel trypsinization at 37°C. Pep-
tides were extracted using 5% formic acid/50% aceto-
nitrile followed by 2.5% formic acid/50% acetonitrile,
both for 1 hour at 37°C. The extracts were mixed to-
gether and dried under vacuum. Visible solids were re-
dissolved using 0.1% formic acid and desalted using aWaters Oasis® HLB 1 cc Extraction Cartridge (Waters
Corporation, Milford, Massachusetts, USA). The elution
fractions obtained in 90% acetonitrile were dried again
and stored at -80°C until use.
The samples were dissolved in 10 μL of 0.1% formic
acid prior to LC-MS/MS analysis. The samples were
loaded using a maximum volume of 8 μL and were sepa-
rated using an Agilent 1200 HPLC system at a flow rate
of 500 μL/min on in-house-produced 100 μm× 150 mm
C18 capillary columns packed with Sunchrom packing
material (SP-120-3-ODS-AQ, 3 μm, The Great Eur-Asia
Sci-Tech Development Co. Ltd, Beijing, China). The sam-
ples were eluted using water/ACN/formic acid gradients
over 120 min and analyzed using LTQ Orbitrap Velos
mass spectrometry (Thermo Fisher Scientific). The experi-
mental group and the control group were analyzed separ-
ately using two different columns. MS scans were acquired
over the 300–2000 m/z range with the resolution set to a
value of 60,000, and the 20 most intense ions in each full
MS scan were selected for CID MS/MS analysis. Dynamic
exclusion was set to 15 s.
The raw MS files were processed using Distiller 2.4.3 and
searched using MASCOT 2.4.0. First, an error-tolerant
search was employed to discover the most frequent modifi-
cations because formaldehyde has been reported to modify
amino acids [5]. The maximum mass deviations for the
parent and fragment ions were set to 5 ppm and 0.5 Da,
respectively. The MS/MS data were analyzed and matched
to protein sequences in the SwissProt_2012_07 database,
with the taxonomy filter, and the contaminants_20120713
database. The most frequent modifications—acetylation
(N-term), loss of ammonia (N-term C), carbamidomethyl-
ation (DEHY), carbamidomethylation (N-term), deamida-
tion (NQ), formyl (N-term) and oxidation (M)—were
specified as variable modifications. The fixed modification
was carbamidomethylation (C). Mascot searches were
conducted with a maximum of two missed cleavages, a
peptide mass tolerance of 5 ppm, and a fragment mass tol-
erance of 0.8 Da.
Additional files
Additional file 1: Figure S1. Formaldehyde cross-linking of human
blood samples from two volunteers. Human blood was incubated with
various concentrations of formaldehyde for 5 s or with 10% formaldehyde
for various times, samples were analyzed using SDS-PAGE.The electrophoresis
patterns observed in two sets of cross-linked samples from two volunteers
(figure S1A and figure S1B were patterns of samples from volunteer A and B,
respectively) were nearly the same, which indicated good biological and
technical reproducibility.
Additional file 2: Table S1. Original peptide sequences for identified
proteins in each molecular weight range.
Additional file 3: Table S2. Number of Significant Matches in Albumin
Immunoprecipitation.
Additional file 4: Table S3. Peptide match data for identified proteins
in each molecular weight range.
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